Mainz Biomed teams up with Dante Labs to sell colorectal cancer test in Italy, UAE

May 19, 2022 5:25 AM ETMainz Biomed B.V. (MYNZ)By: Ravikash, SA News Editor

Business agreement

mediaphotos/iStock via Getty Images

  • Mainz Biomed (NASDAQ:MYNZ) has partnered with Dante Labs to commercialize its at-home colorectal cancer detection test ColoAlert in Italy and the United Arab Emirates (UAE).
  • Mainz said ColoAlert is currently marketed in Europe, and the collaboration with Dante marks the test's initial launch in the Middle East.
  • The companies will first launch ColoAlert in Italy and the UAE using Dante's commercial channels.
  • Mainz said in a May 19 press release that samples will initially be processed at its in-house facility and then Dante will buy Mainz's CE-IVD polymerase chain reaction (PCR) assay kits and transition all test processing to Dante's automated genomic sequencing laboratories in Italy and Dubai to offer localized service.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.